CEL-SCI CORPORATION

CVM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $6.0M
SG&A Expense $5.7M
Operating Income $-12.0M
Operating Margin
Interest Expense $-397.9K
Pretax Income
Income Tax Expense
Net Income $-40.9M
Net Margin
EPS (Basic) $-0.08
EPS (Diluted) $-0.08
Shares Outstanding (Basic) 534.1M
Shares Outstanding (Diluted) 534.1M
Dividends Per Share
← Newer Page 3 of 3 Older →